Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study tests if coaching and cash for fun activities can beat heart disease

NCT ID NCT07282418

Disease control Sponsor: Rush University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether helping people engage in more recreational activities—through coaching and financial support—can improve cardiometabolic health. Researchers will enroll 120 adults, measure their health using the Life's Essential 8 score, and randomly assign some to a 6-month recreation-focused intervention. The goal is to see if increasing access to enjoyable activities can displace unhealthy behaviors like poor diet and inactivity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Recreation Enhancement (coaching and financial support for recreational activities)
What this could lead to
If successful, this could point toward a low-cost, non-drug approach to improve heart health and reduce risks for diabetes and stroke by making healthy activities more accessible.
What could go wrong
This is an early pilot study with only 120 participants, so results may not apply broadly. The intervention is behavioral and may not produce lasting changes in health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility criteria for BEAR main cohort enrollment (N=120): * Age 18 years or older * Fluent in English * Lives within 10 miles of the study site * Not planning to move outside the study region in the next 6 months * Has a working Android or iOS mobile device they are willing to use for EMA surveys and communication with the study team * No apparent cognitive deficits that would suggest a lack of capacity to consent or complete study procedures * No uncontrolled serious mental illness, marked by an inpatient hospitalization, increase or change in antipsychotic or mood stabilizing medication, or suicidal intent in the past 6 months. Eligibility for selection into the RCT component (n=60): * At least 75% adherence to EMA surveys during the initial assessment * Complete baseline data within the observational cohort component * Participant endorses engagement in recreation less than 4 times per week based on EMA surveys * LE8 score \<70, reflecting low to moderate cardiometabolic health. * No serious substance abuse problem based on an ASSIST score of ≥27 for any substance other than tobacco or cannabis * Willing and able to try recreational activities for the next 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiometabolic health indicators are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiometabolic health indicators

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rush University Medical Center

    RECRUITING

    Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.